arrow
Y

Yoshihiko Taniguchi

nho kinki chuo chest medical center
H指数:24
被引数:1,949

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating Tumour DNA in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer and Early Disease Progression After First-Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study

携带EGFR突变非小细胞肺癌患者经第一线奥希替尼治疗后早期疾病进展的循环肿瘤DNA:ELUCIDATOR多中心前瞻性观察研究

2025-04-050
OAAI
Updated results of a prospective observational multicenter study on resistance mechanisms to osimertinib using circulating tumor DNA analyses in EGFR-mutated non- small cell lung cancer patients (ELUCIDATOR study)
2024-03-220
PRE
Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study
2022-07-0113
OA
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study
2021-04-0128
OAAI
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion

贝伐单抗联合卡铂/白蛋白结合型紫杉醇治疗非鳞状非小细胞肺癌恶性胸腔积液的2期研究

2021-02-0511
PREAI
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
2020-09-1485
OAAI